Manning Named Chief of Oncology at Cone Health
His appointment comes after a nationwide search.
Greensboro—Matthew Manning, MD, has been named chief of oncology at Cone Health. He has served as interim oncology chief since October 2018.
As chief of oncology, Manning will provide leadership, vision and direction for the medical staff of Cone Health Cancer Center.
Dr. Matt Manning
He will have responsibility for cancer services and research across Cone Health. “Dr. Manning will be integral in further strengthening our oncology service line to expand research and excellent care at the cancer care program,” says Martin A. Portillo, MD, president & chief medical officer, Cone Health Medical Group.
Manning joined Cone Health as a radiation oncologist in 2001. This past September, Manning was inducted as a Fellow by the American Society of Radiation Oncology. He was one of 26 physicians and medical physicists recognized for contributions to the field of radiation oncology and progress in advancing cancer research, education and patient care.
Manning recently served as co-chair of a statewide oncology disaster preparedness conference. He helped lead Cone Health’s part in the landmark ACCURE clinical trial, which focused on eliminating racial disparities in cancer treatments. The work was in partnership with the Greensboro Health Disparities Collaborative.
Manning is board certified by the American Board of Radiology. He completed medical school at the Medical College of Virginia and his residency at Medical College of Virginia Hospitals.
Cone Health Cancer Center provides cancer care at Alamance Regional Medical Center, Annie Penn Hospital, MedCenter High Point, MedCenter Mebane, Wesley Long Hospital and Randolph Hospital as part of a joint venture with Randolph Health.